Andrew Quecan

Andrew Quecan

Dorsey & Whitney LLP

Contact
View Bio
RSS

Latest Posts › Filing Fees

Share:

USPTO Defers Provisional Filing Fees For COVID-19 Technologies, But Beware Of Early Publication

The USPTO has announced yet another COVID-19 pilot program, which began on September 17, 2020. Under this new pilot, the USPTO allows applicants to defer the application fee for any provisional patent application directed to...more

9/24/2020  /  Biologics , Coronavirus/COVID-19 , Filing Fees , Investigational New Drug Application (IND) , Patent Applications , Patent Fees , Pharmaceutical Industry , USPTO , USPTO Pilot Program
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide